Events

PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich, Germany on the 5th October 2023. This follows our participation in DxPx US.

PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association (BIVDA)

The Inv€$tival Showcase in Old Billingsgate, London, is part of Europe’s biggest healthcare investment week. It will feature Actiphage TB, a groundbreaking diagnostic for tuberculosis.

PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations

The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.

The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be an opportunity to find out more about phage-based diagnostics.

The Microbiology Society Annual Conference 2023 will take place 17 -20 April 2023 at Birmingham International Convention Centre.

The role of phage-based laboratory diagnostics in the detection of tuberculosis is to be discussed in a live webinar hosted by the AACC, it has been announced ahead of World TB Day.

With advances in diagnostics, can we now begin to practice preventative medicine rather than treating the symptoms?

Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022